{
    "predictions": [
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "OCCURRENCE",
            "entity1_begin": "8",
            "entity1_end": "15",
            "chunk1": "admitted",
            "entity2": "CLINICAL_DEPT",
            "entity2_begin": "20",
            "entity2_end": "30",
            "chunk2": "Mayo Clinic",
            "confidence": "0.9999999"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "OCCURRENCE",
            "entity1_begin": "8",
            "entity1_end": "15",
            "chunk1": "admitted",
            "entity2": "DURATION",
            "entity2_begin": "32",
            "entity2_end": "41",
            "chunk2": "three days",
            "confidence": "0.9995034"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "BEFORE",
            "entity1": "OCCURRENCE",
            "entity1_begin": "8",
            "entity1_end": "15",
            "chunk1": "admitted",
            "entity2": "PROBLEM",
            "entity2_begin": "72",
            "entity2_end": "95",
            "chunk2": "Type 2 diabetes mellitus",
            "confidence": "0.9994491"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "20",
            "entity1_end": "30",
            "chunk1": "Mayo Clinic",
            "entity2": "DURATION",
            "entity2_begin": "32",
            "entity2_end": "41",
            "chunk2": "three days",
            "confidence": "0.53755033"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "BEFORE",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "20",
            "entity1_end": "30",
            "chunk1": "Mayo Clinic",
            "entity2": "PROBLEM",
            "entity2_begin": "72",
            "entity2_end": "95",
            "chunk2": "Type 2 diabetes mellitus",
            "confidence": "0.9999999"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "DURATION",
            "entity1_begin": "32",
            "entity1_end": "41",
            "chunk1": "three days",
            "entity2": "PROBLEM",
            "entity2_begin": "72",
            "entity2_end": "95",
            "chunk2": "Type 2 diabetes mellitus",
            "confidence": "0.94303304"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "BEFORE",
            "entity1": "EVIDENTIAL",
            "entity1_begin": "102",
            "entity1_end": "109",
            "chunk1": "reported",
            "entity2": "PROBLEM",
            "entity2_begin": "114",
            "entity2_end": "123",
            "chunk2": "discomfort",
            "confidence": "0.99984896"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "BEFORE",
            "entity1": "EVIDENTIAL",
            "entity1_begin": "102",
            "entity1_end": "109",
            "chunk1": "reported",
            "entity2": "PROBLEM",
            "entity2_begin": "140",
            "entity2_end": "148",
            "chunk2": "dizziness",
            "confidence": "0.9993954"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "PROBLEM",
            "entity1_begin": "114",
            "entity1_end": "123",
            "chunk1": "discomfort",
            "entity2": "PROBLEM",
            "entity2_begin": "140",
            "entity2_end": "148",
            "chunk2": "dizziness",
            "confidence": "1.0"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "BEFORE",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "151",
            "entity1_end": "178",
            "chunk1": "The diabetes management team",
            "entity2": "OCCURRENCE",
            "entity2_begin": "207",
            "entity2_end": "214",
            "chunk2": "released",
            "confidence": "0.7440161"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "151",
            "entity1_end": "178",
            "chunk1": "The diabetes management team",
            "entity2": "DATE",
            "entity2_begin": "219",
            "entity2_end": "228",
            "chunk2": "04/02/2018",
            "confidence": "0.7224586"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "151",
            "entity1_end": "178",
            "chunk1": "The diabetes management team",
            "entity2": "TREATMENT",
            "entity2_begin": "266",
            "entity2_end": "280",
            "chunk2": "insulin detemir",
            "confidence": "0.773744"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "151",
            "entity1_end": "178",
            "chunk1": "The diabetes management team",
            "entity2": "TREATMENT",
            "entity2_begin": "295",
            "entity2_end": "308",
            "chunk2": "insulin aspart",
            "confidence": "0.9144723"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "151",
            "entity1_end": "178",
            "chunk1": "The diabetes management team",
            "entity2": "TREATMENT",
            "entity2_begin": "328",
            "entity2_end": "336",
            "chunk2": "metformin",
            "confidence": "0.9966182"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "CLINICAL_DEPT",
            "entity1_begin": "151",
            "entity1_end": "178",
            "chunk1": "The diabetes management team",
            "entity2": "FREQUENCY",
            "entity2_begin": "345",
            "entity2_end": "355",
            "chunk2": "twice daily",
            "confidence": "0.96690613"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "OCCURRENCE",
            "entity1_begin": "207",
            "entity1_end": "214",
            "chunk1": "released",
            "entity2": "DATE",
            "entity2_begin": "219",
            "entity2_end": "228",
            "chunk2": "04/02/2018",
            "confidence": "1.0"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "OCCURRENCE",
            "entity1_begin": "207",
            "entity1_end": "214",
            "chunk1": "released",
            "entity2": "TREATMENT",
            "entity2_begin": "266",
            "entity2_end": "280",
            "chunk2": "insulin detemir",
            "confidence": "0.99816835"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "OCCURRENCE",
            "entity1_begin": "207",
            "entity1_end": "214",
            "chunk1": "released",
            "entity2": "TREATMENT",
            "entity2_begin": "295",
            "entity2_end": "308",
            "chunk2": "insulin aspart",
            "confidence": "0.9949574"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "OCCURRENCE",
            "entity1_begin": "207",
            "entity1_end": "214",
            "chunk1": "released",
            "entity2": "TREATMENT",
            "entity2_begin": "328",
            "entity2_end": "336",
            "chunk2": "metformin",
            "confidence": "0.999843"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "OCCURRENCE",
            "entity1_begin": "207",
            "entity1_end": "214",
            "chunk1": "released",
            "entity2": "FREQUENCY",
            "entity2_begin": "345",
            "entity2_end": "355",
            "chunk2": "twice daily",
            "confidence": "0.938975"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "DATE",
            "entity1_begin": "219",
            "entity1_end": "228",
            "chunk1": "04/02/2018",
            "entity2": "TREATMENT",
            "entity2_begin": "266",
            "entity2_end": "280",
            "chunk2": "insulin detemir",
            "confidence": "0.7810444"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "DATE",
            "entity1_begin": "219",
            "entity1_end": "228",
            "chunk1": "04/02/2018",
            "entity2": "TREATMENT",
            "entity2_begin": "295",
            "entity2_end": "308",
            "chunk2": "insulin aspart",
            "confidence": "0.9966371"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "DATE",
            "entity1_begin": "219",
            "entity1_end": "228",
            "chunk1": "04/02/2018",
            "entity2": "TREATMENT",
            "entity2_begin": "328",
            "entity2_end": "336",
            "chunk2": "metformin",
            "confidence": "0.94926614"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "AFTER",
            "entity1": "DATE",
            "entity1_begin": "219",
            "entity1_end": "228",
            "chunk1": "04/02/2018",
            "entity2": "FREQUENCY",
            "entity2_begin": "345",
            "entity2_end": "355",
            "chunk2": "twice daily",
            "confidence": "0.71109295"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "TREATMENT",
            "entity1_begin": "266",
            "entity1_end": "280",
            "chunk1": "insulin detemir",
            "entity2": "TREATMENT",
            "entity2_begin": "295",
            "entity2_end": "308",
            "chunk2": "insulin aspart",
            "confidence": "0.9999869"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "TREATMENT",
            "entity1_begin": "266",
            "entity1_end": "280",
            "chunk1": "insulin detemir",
            "entity2": "TREATMENT",
            "entity2_begin": "328",
            "entity2_end": "336",
            "chunk2": "metformin",
            "confidence": "0.99954754"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "TREATMENT",
            "entity1_begin": "266",
            "entity1_end": "280",
            "chunk1": "insulin detemir",
            "entity2": "FREQUENCY",
            "entity2_begin": "345",
            "entity2_end": "355",
            "chunk2": "twice daily",
            "confidence": "0.9987704"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "TREATMENT",
            "entity1_begin": "295",
            "entity1_end": "308",
            "chunk1": "insulin aspart",
            "entity2": "TREATMENT",
            "entity2_begin": "328",
            "entity2_end": "336",
            "chunk2": "metformin",
            "confidence": "0.99985456"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "TREATMENT",
            "entity1_begin": "295",
            "entity1_end": "308",
            "chunk1": "insulin aspart",
            "entity2": "FREQUENCY",
            "entity2_begin": "345",
            "entity2_end": "355",
            "chunk2": "twice daily",
            "confidence": "1.0"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "TREATMENT",
            "entity1_begin": "328",
            "entity1_end": "336",
            "chunk1": "metformin",
            "entity2": "FREQUENCY",
            "entity2_begin": "345",
            "entity2_end": "355",
            "chunk2": "twice daily",
            "confidence": "1.0"
        },
        {
            "document": "She was admitted to Mayo Clinic three days ago following a diagnosis of Type 2 diabetes mellitus. She reported no discomfort or episodes of dizziness. The diabetes management team evaluated her, and she was released on 04/02/2018 with a prescription for 30 units of insulin detemir, 10 units of insulin aspart before meals, and metformin 850 mg twice daily. She was scheduled for regular follow-up appointments with the diabetes care team after her discharge.",
            "relation": "OVERLAP",
            "entity1": "OCCURRENCE",
            "entity1_begin": "380",
            "entity1_end": "409",
            "chunk1": "regular follow-up appointments",
            "entity2": "OCCURRENCE",
            "entity2_begin": "445",
            "entity2_end": "457",
            "chunk2": "her discharge",
            "confidence": "0.9686197"
        }
    ]
}